Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: An incremental cost-effectiveness analysis

Annals of Internal Medicine

Volumn 124, Issue 4, 1996, Pages 389-399

  Magid, David ^b   Douglas Jr , John M ^a   Schwartz, J Sanford ^c  

^a Denver Disease Control Service   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; GENITAL TRACT INFECTION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UTERINE CERVICITIS;

EID: 0030039987     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-4-199602150-00002     Document Type: Article

References (59)

1. Washington AE, Johnson RE, Sanders LL Jr. Chlamydia trachomatis infections in the United States. What are they costing us? JAMA. 1987,257: 2070-2
2. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Morb Mortal Wkly Rep. 1993,42(RR-12).1-39
3. 1993 sexually transmitted diseases treatment guidelines MMWR Morb Mortal Wkly Rep 1993,42(RR-14)-1-102
4. Chlamydia trathomatis infections Policy guidelines for prevention and control MMWR Morb Mortal Wkly Rep 1985;34(Suppl 3):53S-74S.
5. Jordan WC. Doxycycline vs tetracycline in the treatment of men with gonorrhea Sex Transm Dis 1981;8(Suppl) 105-9
6. Katz BP, Zwickl BW, Caine VA, Jones RB. Compliance with antibiotic therapy for Chlamydia frachomatis and Neisseria gonorrhoeas Sex Transm Dis 1992,19:351-4
7. Brookoff D. Compliance with outpatient antibiotics among women treated in the emergency department (or pelvic inflammatory disease Ann Emerg Med 1992;21.621
8. Stamm WE. Problems in the treatment of bacterial sexually transmitted diseases Am J Med. 1987,82(4A) 307-10
9. Martin DH, Mroczkowski TF. Dalu ZA, McCarty J, Jones RB, Hopkins SJ, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis Azithromycin for Chlamydial Infections Study Group N Engl J Med 1992,327 921-5.
10. Steingrimsson O, Olafsson JH, Thorarinsson H, Ryan RW, Johnson RB, Tilton RC. Azithromycin in the treatment of sexually transmitted disease J Antimicrob Chemother 1990,25(Suppl A). 109-14.
11. Lassus A. Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species J Antimicrob Chemother 1990,25(Suppl A).115-21
12. Hammerschlag MR, Golden NH, Oh MK, Gelling M, Sturdevant M, Brown PR, et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents J Pediatr. 1993;122:961-5
13. Lauharanta J, Saarinen K, Mustonen MT, Happonen HP. Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males J Antimicrob Chemother 1993,31(Suppl E):177-83
14. Lister PJ, Balechandran T, Ridgway GL, Robinson AJ. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men J Antimicrob Chemother 1993,31(Suppl E):185-92
15. Nilsen A, Halsos A, Johansen A, Hansen E, Torud E, Moseng D, et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydia urethritis in males Genitourin Med 1992,68:325-7
16. Price Alert 1996,7 27-84.
17. Johannisson G. Lowhagen GB, Lycke E. Genital Chlamydia trachomatis infection in women Obstet Gynecol 1980;56 671-5
18. Romanowski B, Talbot H, Stadnyk M, Kowaichuk P, Bowie WR. Minocycline compared with doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis Ann Intern Med 1993,119 16-22.
19. Sande MA, Mandell GL. Antimicrobial agents (tetracycline, chloramphenicol, erythromycin, and miscellaneous bacterial agents) In Goodman LS, Gilman AG The Pharmacological Basis of Therapeutics. New York Pergamon Pr; 1990 1117-45
20. Gelman CR, Rumack BM, eds. Doxycycline drug evaluation monograph DRUGDEX Information System Vol 72 Denver Micromedex, 1992
21. Scheife RT, Levy M, Greenblatt DR, eds. Drug Effects in Hospitalized Patients Experiences of the Boston Collaborative Drug Surveillance Program, 1966-1975 New York J Wiley, 1976 263-4
22. Hopkins S. Clinical toleration and safety of azithromycin Am J Med 1991, 91(3A) 40S-5S
23. Mansoor GA, Panner BJ, Ornt DB. Azithromycin-induced acute interstitial nephritis [Letter] Ann Intern Med 1993,119 636-7
24. Westrom L, Svensson L, Wolner-Hansen P, Mardh PA. Chlamydial and gonococcal infections in a defined population of women. Scand J Infect Dis Suppl 1982,32 157-62
25. Stamm WE, Guinan ME, Johnson C, Starcher T, Holmes KK, McCormack WM. Effect of treatment regimens for Neisseria gonorrhoea? on simultaneous infection with Chlamydia trachomatis M Engl J Med. 1984;310 545-9
26. Washington AE, Sweet RL, Shafer MA. Pelvic inflammatory disease and its sequelae in adolescents J Adolesc Health Care 1985;6:298-310
27. Washington AE, Arno PS, Brooks MA. The economic cost of pelvic inflammatory disease JAMA 1986,255 1735-8.
28. Washington AE, Cates W Jr, Zaidi AA. Hospitalizations for pelvic inflammatory disease Epidemiology and trends in the United States, 1975 to 1981 JAMA 1984,251:2529-33
29. Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease Trends and projections, 1983 through 2000 JAMA 1991;266 2565-9.
30. Westrom L. Effect of acute pelvic inflammatory disease on fertility Am J Obstet Gynecol 1975;121 707-13
31. Westrom L Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries Am J Obstet Gynecol 1980,138:880-92
32. Svensson L. Mardh PA, Westrom L. Infertility after acute salpingitis with special reference to Chlamydia trachomatis. Fertil Steril 1983;40.322-9
33. Westrom L, Joesoef R, Reynolds G. Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility A cohort study of 1,944 women with laporascopically verified disease and 657 control women with normal laporascopic results Sex Transm Dis 1992,19.185-92
34. Nettleman MD, Bell TA. Cost-effectiveness of prenatal testing for Chlamydia trachomatis Am J Obstet Gynecol. 1991;164 1289-94.
35. Trachtenberg AI, Washington AE, Halldorson S. A cost based decision analysis for Chlamydia screening in California family planning clinics. Obstet Gynecol. 1988;71.101-8
36. Nettleman MD, Jones RB, Roberts SD, Katz BP, Washington AE, Dittus RS, et al. Cost-effectiveness of culturing for Chlamydia trachomatis. A study in a clinic for sexually transmitted diseases. Ann Intern Med. 1986,105 189-96
37. Randolph AG, Washington AE. Screening for Chlamydia trachomatis in adolescent males A cost-based decision analysis. Am J Public Health 1990, 80:545-50
38. Gen M, Ruusuvaara L, Mardh PA. An economic evaluation of screening for Chlamydia trachomatis in adolescent males JAMA 1993,270:2057-64.
39. Kaufman RE, Wiesner PJ. Nonspecific urethritis N Engl J Med. 1974,291 1175-7.
40. Thompson SE, Washington AE. Epidemiology of sexually transmitted Chlamydia trachomatis infections Epidemiol Rev 1983,5.96-123
41. Terho P. Chlamydia trachomatis in non-specific urethritis Br J Vener Dis 1978,54 251-6.
42. Schachter J, Grossman M, Holt J, Sweet R, Goodner E, Mills J. Prospective study of chlamydial infection in neonates Lancet 1979,2:377-9.
43. Hammerschlag MR, Chandler JW, Alexander ER, English M, Koutsky L. Longitudinal studies on chlamydial infections in the first year of life Pediatr Infect Dis. 1982,1 395-401
44. Bell TA. Sandstrom KI, Gravett MG, Mohan K, Kuo CC, Stamm WE, et al. Comparison of ophthalmic silver nitrate solution and erythromycin ointment for prevention of natally acquired Chlamydia trachomatis Sex Transm Dis 1987,14 195-200.
45. Schachter J, Grossman M, Sweet RL, Holt J, Jordan C. Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986,255 3374-7
46. Schachter J, Sweet RL. Grossman M, Landers D, Robbie M. Bishop E. Experience with the routine use of erythromycin for chlamydial infections in pregnancy: N Engl J Med. 1986,314:276-9
47. Arya OP, Atergant CD, Annels EH, Carey PB, Ghosh AK, Goddard AD. Management of non-specific urethritis in men. Evaluation of six treatment regimens and effect of other factors including alcohol and sexual intercourse. Br J Vener Dis 1978,54.414-21.
48. Understanding AWP First Data Bank Monthly Interest. 1991,6.1-3.
49. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990,113.147-54
50. Lieu TA, Cochi SL, Black SB, Halloren ME, Shinefield HR, Holmes SJ, et al. Cost-effectiveness of a routine varicella vaccination program for US Children. JAMA. 1994.271 375-81.
51. Washington AE, Browner WS, Korenbrot CC. Cost-effectiveness of combined treatment for endocervical gonorrhea Considering co-infection with Chlamydia trachomatis. JAMA 1987,257 2056-60
52. Nettleman MD, Jones RB. Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis JAMA. 1988,260 207-13
53. Phillips RS, Aronson MD, Taylor WC, Safran C. Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med 1987;107 188-94.
54. Estany A, Todd M, Vasquez M, McLaren R. Early detection of genital chlamydial infection in women, an economic evaluation. Sex Transm Dis. 1989:16 21-7
55. Buhaug H, Skjeldestad FE, Halvorsen LE, Dalen A. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Br J Gen Pract. 1990;40 142-5
56. Gump DW, Gibson M, Ashikaga T. Evidence of prior pelvic inflammatory disease and its relationship to Chlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women Am J Obstet Gynecol. 1983, 146 153-9.
57. Wasserheit JN. Epidemiological synergy Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases Sex Transm Dis 1992,19:61-77.
58. Schmid GP, Fontanarosa PB. Evolving strategies for management of nongonococcal urethritis syndrome [Editorial]. JAMA 1995;274.577-9
59. Cunningham FG, MacDonald PC, Leveno KJ, Gant NF, Gilstrap LC, eds. Williams Obstetrics Norwalk: Appleton & Lange: 1993:2